Skip to main content
Top
Published in: Surgery Today 1/2017

Open Access 01-01-2017 | Original Article

Clinicopathological characteristics of cancer associated with Crohn’s disease

Authors: Hirofumi Sasaki, Hiroki Ikeuchi, Toshihiro Bando, Kei Hirose, Akihiro Hirata, Teruhiro Chohno, Yuki Horio, Naohiro Tomita, Seiichi Hirota, Yoshihiro Ide, Yasuaki Tsuchida, Motoi Uchino

Published in: Surgery Today | Issue 1/2017

Login to get access

Abstract

Purpose

We examined the clinicopathological characteristics and prognosis of patients with cancer associated with Crohn’s disease (CD).

Methods

The subjects of this study were patients with cancer confirmed in a resected specimen of bowel, who were treated at our institution between September, 1974 and December, 2014.

Results

We analyzed 34 patients (26 men, 8 women, median age at cancer diagnosis 43.5 years, duration of illness 18 years) and found that the number of those with CD complicated with cancer began to drastically increase after 2005. The site of onset of cancer was in an anorectal lesion in 24 (70.6 %) patients. In 17 (50 %) patients, the cancer was diagnosed before surgery; in 3 patients (8.8 %), it was based on pathological findings during surgery; and in 14 patients (41.2 %), it was based on postoperative pathological findings. Mucinous carcinoma was the dominant histological type, seen in 15 patients (44.1 %), while the special type of signet-ring cell carcinoma was found in 4 patients. The cumulative overall 5 year survival rate was 46.2 %.

Conclusion

In this group of Japanese CD patients, an anorectal lesion was the most frequent site of origin of cancer. As cancer was diagnosed preoperatively in only 50 % of these patients, the overall prognosis was poor, with a cumulative 5 year survival rate of just 46.2 %.
Literature
1.
go back to reference Ullman TA. Dysplasia and colorectal cancer in Crohn’s disease. J Clin Gastroenterol. 2003;36:S75–8.CrossRefPubMed Ullman TA. Dysplasia and colorectal cancer in Crohn’s disease. J Clin Gastroenterol. 2003;36:S75–8.CrossRefPubMed
2.
go back to reference Sjӧdahl RI, Myrelid P, Sӧderholm JD. Anal and rectal cancer in Crohn’s disease. Colorectal Dis. 2003;5:490–5.CrossRef Sjӧdahl RI, Myrelid P, Sӧderholm JD. Anal and rectal cancer in Crohn’s disease. Colorectal Dis. 2003;5:490–5.CrossRef
3.
go back to reference Jess T, Gamborg M, Matzen P, Munkholm P, S¢rensen IA. Increased risk of intestinal cancer in Crohn’s disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol. 2005;100:2724–9.CrossRefPubMed Jess T, Gamborg M, Matzen P, Munkholm P, S¢rensen IA. Increased risk of intestinal cancer in Crohn’s disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol. 2005;100:2724–9.CrossRefPubMed
4.
go back to reference Ky A, Sohn N, Weinstein MA, Korelitz BI. Carcinoma arising in anorectal fistulas of Crohn’s disease. Dis Colon Rectum. 1998;41:992–6.CrossRefPubMed Ky A, Sohn N, Weinstein MA, Korelitz BI. Carcinoma arising in anorectal fistulas of Crohn’s disease. Dis Colon Rectum. 1998;41:992–6.CrossRefPubMed
5.
go back to reference Connell WR, Sheffield JP, Kamm MA, Ritchie JK, Hawley PR, Lennard-Jones JE. Lower gastrointestinal malignancy in Crohn’s disease. Gut. 1994;35:347–52.CrossRefPubMedPubMedCentral Connell WR, Sheffield JP, Kamm MA, Ritchie JK, Hawley PR, Lennard-Jones JE. Lower gastrointestinal malignancy in Crohn’s disease. Gut. 1994;35:347–52.CrossRefPubMedPubMedCentral
6.
go back to reference Higashi D, Futami K, Kawahara K, Kamitani T, Seki K, Naritomi K, et al. Study of colorectal cancer with Crohn’s disease. Anticancer Res. 2007;27:3771–4.PubMed Higashi D, Futami K, Kawahara K, Kamitani T, Seki K, Naritomi K, et al. Study of colorectal cancer with Crohn’s disease. Anticancer Res. 2007;27:3771–4.PubMed
8.
go back to reference Sjödahl RI, Myrelid P, Söderholm D. Anal and rectal cancer in Crohn’s disease. Colorectal Dis. 2003;5:490–5.CrossRefPubMed Sjödahl RI, Myrelid P, Söderholm D. Anal and rectal cancer in Crohn’s disease. Colorectal Dis. 2003;5:490–5.CrossRefPubMed
9.
go back to reference Savoca PE, Ballantyne GH, Cahow CE. Gastrointestinal malignancies in Crohn’s disease. A 20-year experience. Dis Colon Rectum. 1990;33:7–11.CrossRefPubMed Savoca PE, Ballantyne GH, Cahow CE. Gastrointestinal malignancies in Crohn’s disease. A 20-year experience. Dis Colon Rectum. 1990;33:7–11.CrossRefPubMed
10.
go back to reference Mizushima T, Ohno Y, Nakajima K, Kai Y, Iijima H, Sekimoto M, et al. Malignancy in Crohn’s disease. Incidence and clinical characteristics in Japan. Digestion. 2010;81:265–70.CrossRefPubMed Mizushima T, Ohno Y, Nakajima K, Kai Y, Iijima H, Sekimoto M, et al. Malignancy in Crohn’s disease. Incidence and clinical characteristics in Japan. Digestion. 2010;81:265–70.CrossRefPubMed
11.
go back to reference Roon AC, Reese G, Teare J, Constantinides V, Darzi AW, Tekkis PP. The risk of cancer in patients with Crohn’s disease. Dis Colon Rectum. 2007;50:839–55.CrossRef Roon AC, Reese G, Teare J, Constantinides V, Darzi AW, Tekkis PP. The risk of cancer in patients with Crohn’s disease. Dis Colon Rectum. 2007;50:839–55.CrossRef
12.
go back to reference Scaringi S, Martino CD, Zambonin D, Fazi M, Canonico G, Leo F, et al. Colorectal cancer and Crohn’s colitis: clinical implications from 313 surgical patients. World J Surg. 2013;37:902–10.CrossRefPubMed Scaringi S, Martino CD, Zambonin D, Fazi M, Canonico G, Leo F, et al. Colorectal cancer and Crohn’s colitis: clinical implications from 313 surgical patients. World J Surg. 2013;37:902–10.CrossRefPubMed
13.
go back to reference Neurath MF, Vehling D, Schunk K, Holtmann M, Brockmann H, Helisch A, et al. Noninvasive assessment of Crohn’s disease activity: a comparison of 18F-fluorodeoxyglucose positron emission tomography, hydromagnetic resonance imaging, and granulocyte scintigraphy with labeled antibodies. Am J Gastroenterol. 2002;97:1978–85.CrossRefPubMed Neurath MF, Vehling D, Schunk K, Holtmann M, Brockmann H, Helisch A, et al. Noninvasive assessment of Crohn’s disease activity: a comparison of 18F-fluorodeoxyglucose positron emission tomography, hydromagnetic resonance imaging, and granulocyte scintigraphy with labeled antibodies. Am J Gastroenterol. 2002;97:1978–85.CrossRefPubMed
14.
go back to reference Lemberg DA, Issenman RM, Cawdron R, Green T, Mernagh J, Skehan SJ, et al. Positron emission tomography in the investigation of pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2005;11:733–8.CrossRefPubMed Lemberg DA, Issenman RM, Cawdron R, Green T, Mernagh J, Skehan SJ, et al. Positron emission tomography in the investigation of pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2005;11:733–8.CrossRefPubMed
15.
go back to reference Löffler M, Weckesser M, Franzius C, Schober O, Zimmer KP. High diagnostic value of 18F-FDG-PET in pediatric patients with chronic inflammatory bowel disease. Ann N Y Acad Sci. 2006;1072:379–85.CrossRefPubMed Löffler M, Weckesser M, Franzius C, Schober O, Zimmer KP. High diagnostic value of 18F-FDG-PET in pediatric patients with chronic inflammatory bowel disease. Ann N Y Acad Sci. 2006;1072:379–85.CrossRefPubMed
16.
go back to reference Ikeuchi H, Nakano H, Uchino M, Nakamura M, Matsuoka H, Takesue Y, et al. Usefulness of FDG-PET for Crohn’s disease. J Jap Coloproctol. 2008;61:303–10 (in Japanese).CrossRef Ikeuchi H, Nakano H, Uchino M, Nakamura M, Matsuoka H, Takesue Y, et al. Usefulness of FDG-PET for Crohn’s disease. J Jap Coloproctol. 2008;61:303–10 (in Japanese).CrossRef
17.
go back to reference Whiteford MH, Whiteford HM, Yee LF, Ogunbiyi OA, Dehdashti F, Siegel BA, et al. Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum. Dis Colon Rectum. 2000;43:759–67.CrossRefPubMed Whiteford MH, Whiteford HM, Yee LF, Ogunbiyi OA, Dehdashti F, Siegel BA, et al. Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum. Dis Colon Rectum. 2000;43:759–67.CrossRefPubMed
18.
go back to reference Sengul N, Wexner SD, Woodhouse S, Arrigain S, Xu M, Larach JA, et al. Effects of radiotherapy on different histopathological types of rectal carcinoma. Colorectal Dis. 2006;8:283–8.CrossRefPubMed Sengul N, Wexner SD, Woodhouse S, Arrigain S, Xu M, Larach JA, et al. Effects of radiotherapy on different histopathological types of rectal carcinoma. Colorectal Dis. 2006;8:283–8.CrossRefPubMed
19.
go back to reference Gaertner WB, Hagerman GF, Finne CO, Alavi K, Jessurun J, Rothenberger DA, et al. Fistula-associated anal adenocarcinoma: good results with aggressive therapy. Dis Colon Rectum. 2008;51:1061–7.CrossRefPubMed Gaertner WB, Hagerman GF, Finne CO, Alavi K, Jessurun J, Rothenberger DA, et al. Fistula-associated anal adenocarcinoma: good results with aggressive therapy. Dis Colon Rectum. 2008;51:1061–7.CrossRefPubMed
20.
go back to reference Matsuoka H, Ikeuchi H, Uchino M, Bando T, Takesue Y, Nishigami T, et al. Clinicopathological features of ulcerative colitis-associated colorectal cancer pointing to efficiency of surveillance colonoscopy in a large retrospective Japanese cohort. Int J Colorectal Dis. 2013;28:829–34.CrossRefPubMed Matsuoka H, Ikeuchi H, Uchino M, Bando T, Takesue Y, Nishigami T, et al. Clinicopathological features of ulcerative colitis-associated colorectal cancer pointing to efficiency of surveillance colonoscopy in a large retrospective Japanese cohort. Int J Colorectal Dis. 2013;28:829–34.CrossRefPubMed
21.
go back to reference Laurent S, Barbeaux A, Detroz B, Detry O, Louis E, Belaiche J, et al. Development of adenocarcinoma in chronic fistula in Crohn’s disease. Acta Gastroenterol Belg. 2005;68:98–100.PubMed Laurent S, Barbeaux A, Detroz B, Detry O, Louis E, Belaiche J, et al. Development of adenocarcinoma in chronic fistula in Crohn’s disease. Acta Gastroenterol Belg. 2005;68:98–100.PubMed
Metadata
Title
Clinicopathological characteristics of cancer associated with Crohn’s disease
Authors
Hirofumi Sasaki
Hiroki Ikeuchi
Toshihiro Bando
Kei Hirose
Akihiro Hirata
Teruhiro Chohno
Yuki Horio
Naohiro Tomita
Seiichi Hirota
Yoshihiro Ide
Yasuaki Tsuchida
Motoi Uchino
Publication date
01-01-2017
Publisher
Springer Japan
Published in
Surgery Today / Issue 1/2017
Print ISSN: 0941-1291
Electronic ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-016-1336-2

Other articles of this Issue 1/2017

Surgery Today 1/2017 Go to the issue